Page last updated: 2024-08-21

resazurin and opc-67683

resazurin has been researched along with opc-67683 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Battaglia, S; Borroni, E; Cabibbe, AM; Cirillo, DM; Hoffmann, H; Hofmann-Thiel, S; Merker, M; Nedialkova, L; Niemann, S; Schena, E; Trovato, A; Utpatel, C1
Bethunaickan, R; Chandramohan, Y; Padmanaban, V; Ranganathan, UD; Swaminathan, S; Tripathy, S1

Other Studies

2 other study(ies) available for resazurin and opc-67683

ArticleYear
Delamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:6

    Topics: Antitubercular Agents; Automation, Laboratory; Colorimetry; Genes, Bacterial; Indicators and Reagents; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazines; Oxazoles; Polymorphism, Genetic; Sequence Analysis, DNA; Xanthenes

2016
In vitro interaction profiles of the new antitubercular drugs bedaquiline and delamanid with moxifloxacin against clinical Mycobacterium tuberculosis isolates.
    Journal of global antimicrobial resistance, 2019, Volume: 19

    Topics: Antitubercular Agents; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Drug Synergism; Extensively Drug-Resistant Tuberculosis; Humans; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Nitroimidazoles; Oxazines; Oxazoles; Tuberculosis, Multidrug-Resistant; Xanthenes

2019